The Effect of Botulinum Toxin A on Headache Attributed to TMD
Clinical trial NCT03346252 · COMPLETED
Trial details
- NCT number
- NCT03346252
- Sponsor
- State University of New York at Buffalo
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2021-03-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.